ANAB 8-K 2026-09-21
ANAPTYSBIO, INC (ANAB) 8-K dated 2026-09-21 — accession 0001193125-26-396690.
ANAPTYSBIO, INC (ANAB) is a biotechnology company listed on NASDAQ.
ANAPTYSBIO, INC filed a 8-K on 2026-09-21. Accession 0001193125-26-396690.
This 8-K covers: Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.
Latest reported ANAB revenue for 2026-09-30 was $30.3M. Net income was $3.9M. Revenue was up 18.5% from 2026-03-31 to 2026-09-30. ANAB currently screens at market cap $1.62B.
Not investment advice. The ANAB SEC hub lists recent forms. The stock page is the research view.